NeoGenesis Capital is a new fund focused on superintelligence and synthetic biology

Peter Diamandis introduced NeoGenesis Capital, a new fund he’s been working on focused on the intersection of superintelligence and synthetic biology. He believes some of the coming decade’s most extraordinary breakthroughs will happen there. In his October 13 announcement, he said he would share more on @moonshots_pod.